{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:28:19Z","timestamp":1790422099267,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Injection of Hylan G-F20 (HY) into joints may provoke local flares, which mechanisms may involve reaction to protein contaminants. We have previously developed a protein-free saline-soluble galactomannan derived from guar gum (GM) that displays both analgesia and chondroprotection in experimental osteoarthritis (OA). We now demonstrate that both GM and Hylan G-F20 (HY) promote mild synovitis with cytokine release after intra-articular injection.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Mice received 100\u2009\u03bcg\/25\u2009\u03bcL GM or HY or saline into the knees. Joint pain was evaluated using von Frey test; cell influx, interleukin (IL)-1, IL-6, and CXCL-1 (pg\/mL) levels were assessed in joint lavage at 6\u2009h. Synovia were excised for histopathology.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Neither GM nor HY after being given into mice knee joints induced pain albeit promoting mild cell influx into joint washings as well as mild synovitis at histology, with no damage to the underlying cartilage. HY but not GM promoted IL-1 release into mice joints. Both compounds induced IL-6 and CXCL-1 release.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Intra-articular injection of HY or GM promote acute transient synovitis whilst not provoking detectable significant joint damage. Local administration of these polysaccharides induces acute intra-articular release of inflammatory cytokines, which may account for joint flares following viscosupplementation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s42358-020-00127-7","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:03:48Z","timestamp":1589198628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hylan G-F20 and galactomannan joint flares are associated to acute synovitis and release of inflammatory cytokines"],"prefix":"10.1186","volume":"60","author":[{"given":"Rodolfo","family":"de Melo Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablyana Leila Rodrigues","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Matias Dinelly","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virg\u00ednia Claudia Carneiro","family":"Gir\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Pessoa","family":"de Andrade Feitosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-3294","authenticated-orcid":false,"given":"Francisco Airton Castro","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1056\/NEJMct1215534","volume":"372","author":"DJ Hunter","year":"2015","unstructured":"Hunter DJ. Viscosupplementation for osteoarthritis of the knee. N Engl J Med. 2015;372:1040\u20137.","journal-title":"N Engl J Med"},{"key":"127_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22:363\u201388.","journal-title":"Osteoarthr Cartil"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee. Arthritis Care Res. 2012;64:465\u201374.","journal-title":"Arthritis Care Res"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruy\u00e8re","year":"2014","unstructured":"Bruy\u00e8re O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO). Seminars in Arthritis Rheumatism. 2014;44:253\u201363.","journal-title":"Seminars in Arthritis Rheumatism"},{"key":"127_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/M14-1231","volume":"162","author":"RR Bannuru","year":"2015","unstructured":"Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162:46\u201354.","journal-title":"Ann Intern Med"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2017.00082","volume":"4","author":"RC Machado","year":"2017","unstructured":"Machado RC, Capela S, Rocha FAC. Polysaccharides as viscosupplementation agents: structural molecular characteristics but not rheology appear crucial to the therapeutic response. Front Med. 2017;4:1\u20135.","journal-title":"Front Med"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0968-0160(01)00075-8","volume":"8","author":"J Kirwan","year":"2001","unstructured":"Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee. 2001;8:93\u2013101.","journal-title":"Knee."},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/rheumatology\/40.2.158","volume":"40","author":"I Pasquali-Ronchetti","year":"2001","unstructured":"Pasquali-Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Zizzi F, et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology. 2001;40:158\u201369.","journal-title":"Rheumatology"},{"key":"127_CR9","first-page":"2611","volume":"29","author":"S Pullman-Mooar","year":"2002","unstructured":"Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, Schumacher HR. Are there distinctive inflammatory flares after Hylan G-F 20 intraarticular injections? J Rheumatol. 2002;29:2611\u20134.","journal-title":"J Rheumatol"},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5152\/eurjrheum.2016.15075","volume":"4","author":"M Aydin","year":"2017","unstructured":"Aydin M, Arikan M, Togral G, Varis O, Audin G. Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review. Eur J Rheumatol. 2017;4:59\u201362.","journal-title":"Eur J Rheumatol"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.joca.2014.08.002","volume":"22","author":"M Ishikawa","year":"2014","unstructured":"Ishikawa M, Yoshioka K, Urano K, Tanaka Y, Hatanaka T, Nii A. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis. Osteoarthr Cartil. 2014;22:1902\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"127_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijbiomac.2007.04.003","volume":"41","author":"PL Cunha","year":"2007","unstructured":"Cunha PL, Paula RC, Feitosa JPA. Purification of guar gum for biological applications. Int J Biol Macromol. 2007;41:324\u201331.","journal-title":"Int J Biol Macromol"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s10067-006-0506-9","volume":"26","author":"RR Castro","year":"2007","unstructured":"Castro RR, Feitosa JPA, da Cunha PL, da Rocha FAC. Analgesic activity of a polysaccharide in experimental osteoarthritis in rats. Clin Rheumatol. 2007;26:1312\u20139.","journal-title":"Clin Rheumatol"},{"key":"127_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.carbpol.2016.05.031","volume":"150","author":"RR Castro","year":"2016","unstructured":"Castro RR, Silva CM, Nunes RM, Cunha PL, de Paula RC, Feitosa JPA, et al. Structural characteristics are crucial to the benefits of guar gum in experimental osteoarthritis. Carbohydr Polym. 2016;150:392\u20139.","journal-title":"Carbohydr Polym"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.joca.2014.07.019","volume":"22","author":"AC de Melo Leite","year":"2014","unstructured":"de Melo Leite AC, Teotonio MA, Gir\u00e3o VC, Lima Pompeu MM, de Melo NR, Cunha TM, et al. Meniscal transection rather than excision increases pain behavior and structural damage in experimental osteoarthritis in mice. Osteoarthr Cartil. 2014;22:1878\u201385.","journal-title":"Osteoarthr Cartil"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1002\/art.23026","volume":"56","author":"P J\u00fcni","year":"2007","unstructured":"J\u00fcni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis & Rheumatism. 2007;56:3610\u20139.","journal-title":"Arthritis & Rheumatism"},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis). Osteoarthr Cartil. 2013;21:16\u201321.","journal-title":"Osteoarthr Cartil"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12891-015-0775-z","volume":"16","author":"RD Altman","year":"2015","unstructured":"Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321.","journal-title":"BMC Musculoskelet Disord"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.smim.2013.12.002","volume":"26","author":"R Davies","year":"2014","unstructured":"Davies R, Choy E. Clinical experience of IL-6 blockade in rheumatic diseases-implications on IL-6 biology and diseases pathogenesis. Semin Immunol. 2014;26:97\u2013104.","journal-title":"Semin Immunol"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"33123","DOI":"10.1038\/srep33123","volume":"6","author":"KV Sawant","year":"2016","unstructured":"Sawant KV, Poluri KM, Dutta AK, Sepuru KM, Troshkina A, Garofalo RP, Rajarathnam K. Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions. Scientific Rep. 2016;6:33123.","journal-title":"Scientific Rep"},{"key":"127_CR21","first-page":"4669","volume":"15","author":"A Mortensen","year":"2017","unstructured":"Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Frutos MJ, Galtier P, Gott D. Re-evaluation of guar gum (E 412) as a food additive. EFSA J. 2017;15:4669\u2013731.","journal-title":"EFSA J"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-020-00127-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T23:07:01Z","timestamp":1620688021000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-020-00127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1186\/s42358-020-00127-7","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures and experimental protocols were approved by our local ethics committee on animal experimentation (protocol number 113\/07). All efforts were made to minimize animal suffering and the number of animals used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author and co-authors declare that there are no conflicts of interest to disclose concerning the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}